Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/25 16:31 | 8/25/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 3 | S.d | -1,042 | 86.87 | 0 | -12 | 48 | D | |||||||||||||||
10/31/25 16:30 | 10/30/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Miller Deborah Ann | MA | O | GC | 3 | S.dm | -5,264 | 96.05 | 0 | -55 | 49 | D | |||||||||||||||
10/29/25 16:31 | 10/27/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Shair Matthew | MA | D | 1 | S.m | -6,015 | 100.26 | 0 | -60 | 1,586 | M | ||||||||||||||||
10/17/25 16:32 | 8/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 3 | S.d | -6,618 | 81.71 | 0 | -81 | 249 | D | |||||||||||||||
10/17/25 16:31 | 10/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Pelish Henry E. | MA | O | Chief Sc | 3 | S.dm | -2,467 | 88.12 | 0 | -28 | 66 | D | |||||||||||||||
10/17/25 16:31 | 10/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Balcom Alexandra | MA | O | CFO | 4 | S.dm | -7,694 | 86.19 | 0 | -89 | 62 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |